HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Direct endolymphatic administration of antitubercular drugs in patients with inflammatory diseases of the urogenital organs].

Abstract
Direct endolymphatic administration of broad-spectrum antibiotics was used in treatment of approximately 21 patients with complicated urogenital tuberculosis. The duration of the endolymphatic therapy ranged from 3 to 13 days. In the patients treated with endolymphatic administration of the antibiotics the effects were favourable. The use of the procedure were shown expedient because marked lesions in the urinary tracts, frequent chronic renal failure and the microbial flora resistance to the drugs lowered the efficacy of the treatment with the routine administration of the drugs. The drugs used i.e. klaforan and gentamicin were approved by the USSR Pharmacological Committee. The drugs were administered with dosator NDL-3 in original modification which provided continuous polycollector endolymphatic antibiotic therapy with simultaneous lavage of the lymphatic channel. It was shown expedient to use endolymphatic administration of antibiotics in treatment of complicated urogenital tuberculosis alone or in combination with the preoperative procedures.
AuthorsT P Mochalova, A L Shapiro, M I Dubinin, A V Polinov, A P Poliachenko
JournalProblemy tuberkuleza (Probl Tuberk) Issue 2 Pg. 40-2 ( 1989) ISSN: 0032-9533 [Print] Russia (Federation)
Vernacular TitlePriamoe éndolimfaticheskoe vvedenie antibakterial'nykh preparatov bol'nym s vospalitel'nymi zabolevaniiami mochepolovykh organov.
PMID2704711 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Antitubercular Agents
Topics
  • Antitubercular Agents (administration & dosage)
  • Cystitis (drug therapy)
  • Humans
  • Injections, Intralymphatic
  • Male
  • Middle Aged
  • Prostatitis (drug therapy)
  • Tuberculosis, Male Genital (drug therapy)
  • Tuberculosis, Renal (drug therapy)
  • Tuberculosis, Urogenital (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: